TORQUE THERAPEUTICS INC has a total of 53 patent applications. It increased the IP activity by 433.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are THUNDER BIOTECH INC, PASTAN IRA H and ALETA BIOTHERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | Australia | 9 | |
#3 | Canada | 9 | |
#4 | EPO (European Patent Office) | 7 | |
#5 | China | 5 | |
#6 | United States | 5 | |
#7 | Republic of Korea | 4 | |
#8 | Brazil | 1 | |
#9 | United Kingdom | 1 | |
#10 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Heterocyclic compounds | |
#6 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Jones Douglas S | 18 |
#2 | Andresen Thomas L | 14 |
#3 | Andresen Thomas Lars | 14 |
#4 | Andresen Thomas | 13 |
#5 | Lyons Jesse | 12 |
#6 | Nielsen Ulrik B | 12 |
#7 | Rakestraw James Andrew | 9 |
#8 | Kraemer Martin Kisha | 8 |
#9 | Nardozzi Jonathan D | 7 |
#10 | Jones Douglas Scott | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020205808A1 | Immunotherapeutic compositions and use thereof | |
WO2020102745A1 | Methods and compositions for cancer immunotherapy | |
AU2019339332A1 | Antigen-specific T lymphocytes and methods of making and using the same | |
AU2019311102A1 | TLR7/8 agonists and liposome compositions | |
KR20210030268A | Peptide display into antigen presenting cells using a lipid vehicle | |
CA3074826A1 | Therapeutic protein compositions and methods of making and using the same | |
CN111432843A | Reversible linkers and uses thereof | |
EP3675892A1 | Immunostimulatory fusion molecules and uses thereof | |
CN109715196A | For promoting the composition and method of immune cell function |